Indication

Macrophage activation syndrome

Macrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis. Read more about Macrophage activation syndrome

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Macrophage activation syndrome therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Macrophage activation syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Macrophage activation syndrome.

Macrophage activation syndrome is a life-threatening, hyperinflammatory state categorized as a secondary form of hemophagocytic lymphohistiocytosis.

It predominantly complicates pediatric and adult autoimmune or autoinflammatory conditions, most notably systemic juvenile idiopathic arthritis, Adult-onset Still's disease, and systemic lupus erythematosus.

Pathophysiologically, it is driven by defective cytotoxic cell function and the uncontrolled activation and expansion of T lymphocytes and macrophages, producing a massive cytokine storm and widespread hemophagocytosis.

Clinically, the syndrome manifests as persistent high fevers, hepatosplenomegaly, lymphadenopathy, cytopenias, marked hyperferritinemia, coagulopathy, hepatic dysfunction, and potential multiorgan failure.

Personalize your experience

Follow Macrophage activation syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it